Evidence map›Paper›PMID 24554801›Full record

ArticleActa informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH2013

Which pharmaceutical sales representatives' features do slovenian family physicians value?

Zalika Klemenc-Ketis, Janko Kersnik

Abstract read
In one paragraph

Article in Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zalika Klemenc-KetisDepartment of Family Medicine, Maribor Medical School, University of Maribor, Maribor, Slovenia ; Department of Family Medicine, Ljubljana Medical School, University of Ljubljana, Ljubljana, Slovenia.
Janko KersnikDepartment of Family Medicine, Maribor Medical School, University of Maribor, Maribor, Slovenia ; Department of Family Medicine, Ljubljana Medical School, University of Ljubljana, Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOne of the key strategies for marketing new drugs to physicians is personal selling by pharmaceutical sales representatives (PSRs). GOAL: The aim of this study was to determine which features of PSR's are most valued by Slovenian family physicians (FPs).

methodsWe performed a cross-sectional observational postal survey in FPs. We sent the invitation for cooperation in the study to all Slovenian FPs working in family practices at the primary level of care (N = 895). Data was collected using a validated PSRs' assessment scale. It consists of 12 questions on PSRs' assessment that could be answered on a seven-point Likert scale.

resultsThe response rate was 27.6%. There were 174 (70.4%) of female physicians among the respondents. Average age of the respondents was 48.3 ± 9.0 years. Highly assessed PSRs' characteristics were "Provides objective product information", "Does not mislead", and "Shows good knowledge on the subject promoted". Worst rated PSRs' characteristics were "Possesses knowledge on health care system", "Same person for the product of company for a longer period of time", and "Acts friendly".

conclusionsSlovenian FPs value PSRs' selling and communication skills and trustworthiness highly. FPs and PSRs develop a personal relationship which reflects in different perceptions of various PSRs' characteristics by FPs.

Indexed as

cross-sectional study.family practicepharmacy

Identifiers

PMID24554801
PMCPMC3916158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.